Dow Down 0.17% Nasdaq Down 0.28%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
5.40 Down 0.38(6.57%) 4:15PM EDT
|After Hours : 5.49 Up 0.09 (1.67%) 7:58PM EDT
Prev Close:5.78
Open:5.76
Bid:5.46 x 1000
Ask:5.52 x 1000
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.40 - 5.76
52wk Range:2.15 - 19.18
Volume:9,364,127
Avg Vol (3m):7,157,370
Market Cap:1.01B
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 6.57%1.01B
NVSUp 0.61%228.38B
PFEDown 0.67%187.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback